Skip to main content

Day: August 2, 2024

Bay Community Bancorp Earns $2.02 Million in Second Quarter 2024

Declares Quarterly Cash Dividend of $0.055 Per Share OAKLAND, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — Bay Community Bancorp, (OTCPink: CBOBA) (the “Company”), parent company of Community Bank of the Bay, (the “Bank”) a San Francisco Bay Area commercial bank and California’s first certified FDIC-insured Community Development Financial Institution (“CDFI”) with full-service offices in Oakland, Danville, San Jose and San Mateo, and a loan production office in San Francisco, today reported net income of $2.08 million for the second quarter of 2024, compared to $1.66 million for the first quarter of 2024 and $1.85 million for the second quarter of 2023. All financial results are unaudited. On July 24, the Company’s Board of Directors declared a quarterly cash dividend of $0.055 per share. The dividend is payable September 4, 2024,...

Continue reading

Cipher Mining Announces July 2024 Operational Update

NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for July 2024. Key HighlightsKey Metrics July 2024BTC Mined1 178BTC Sold 108BTC Held 2,270Deployed Mining Rigs 75,000Month End Operating Hash Rate (EH/s) 8.71 Includes July power sales estimates (based on current meter data and nodal prices) equivalent to 9 bitcoin (using month-end bitcoin price of $63,921) Management Commentary for July Our earnings call is scheduled for Tuesday, August 13th at 8:00 a.m. Eastern Time. Please join then for an update on the business – register here or access the webcast through our investor website at https://investors.ciphermining.com. Bitcoin Production and Operations Updates for July 2024 Cipher produced ~1781...

Continue reading

eXp Commercial Unveils Game-Changing Groups for Unmatched Advisor Collaboration and Streamlined Deals

eXp Commercial Groups offers specialized support and resources for teams and brokerageseXp Commercial Unveils Game-Changing Groups for Unmatched Advisor Collaboration and Streamlined DealseXp Commercial Groups offers specialized support and resources for teams and brokeragesBELLINGHAM, Wash., Aug. 02, 2024 (GLOBE NEWSWIRE) — eXp Commercial, a nationwide virtual commercial real estate brokerage and subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the launch of eXp Commercial Groups, designed to foster growth and collaboration for eXp Commercial advisors and streamline the transaction process for group leaders. eXp Commercial will now offer teams and brokerages two group structures: Domestic Groups and Advisor Groups. Domestic Groups allow legally married couples to benefit from shared commission,...

Continue reading

Arbor Realty Trust Reports Second Quarter 2024 Results and Declares Dividend of $0.43 per Share

Company Highlights:GAAP net income of $0.25 and distributable earnings of $0.45, per diluted common share1 Declares cash dividend on common stock of $0.43 per share Strong liquidity position with ~$725 million in cash and liquidity and ~$215 million of CLO restricted cash2 Agency loan originations of $1.15 billion; a servicing portfolio of ~$32.28 billion, up 3% Structured loan originations of $227.2 million, runoff of $629.6 million and a portfolio of ~$11.87 billion Redeemed our 5.75% senior notes at maturity for ~$90.0 million Repurchased $11.4 million of common stock at an average price of $12.19 per shareUNIONDALE, N.Y., Aug. 02, 2024 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced financial results for the second quarter ended June 30, 2024. Arbor reported net income for the quarter of $47.4 million,...

Continue reading

Big Idea Ventures Portfolio Company Uproot Inc. Acquired by Leading Plant-Based Beverage Brand Califia Farms

NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) — Big Idea Ventures, a global investment leader within the food-tech, agri-tech, and materials science sectors, is happy to announce that its portfolio company Uproot Inc. was acquired by leading, premium, plant-based beverage brand Califia Farms LLC. Uproot Inc.’s dispensing system provides a convenient and sustainable solution for delivering healthy and delicious plant-based milks to health-conscious consumers. Big Idea Ventures was the company’s first investor and the Uproot team took part in the Big Idea Ventures’ New Protein Fund I accelerator program back in 2020. “Since they began, the Uproot team has been absolutely focused on providing a range of products which add significant sustainability gains to the food services category and Universities in particular. We believe the Uproot...

Continue reading

Cumulus Media Reports Operating Results for the Second Quarter 2024

Completed Highly Successful Debt Exchange That Reduced Our Debt Obligations Under Our Debt Instruments by Approximately $33 Million, Extended Maturities to 2029, Obtained Favorable Interest Rates, and Preserved Structure Free of Financial Maintenance Covenants Upsized ABL Facility by 25% to $125 Million and Extended Maturity to 2029 Reported Q2 Total Revenue of $205 Million, Down 2.5%, in Line with Pacing Guidance Increased Digital Marketing Services Revenue by 24%, Total Digital Revenue by 5% ATLANTA, Aug. 02, 2024 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “Cumulus Media,” “we,” “us,” or “our”) today announced operating results for the three and six months ended June 30, 2024. Mary G. Berner, President and Chief Executive Officer of Cumulus...

Continue reading

Plains All American Reports Second-Quarter 2024 Results & Raises 2024 Guidance

HOUSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported strong second-quarter 2024 results and raised full-year 2024 Adjusted EBITDA guidance. Second-Quarter ResultsReported net income attributable to PAA of $250 million and net cash provided by operating activities of $653 millionDelivered Adjusted EBITDA attributable to PAA of $674 millionGenerated Adjusted Free Cash Flow of $421 million (excluding changes in Assets & Liabilities; including bolt-on acquisition capital)Successfully priced public offering of $650 million of unsecured senior notes at 5.7% due 20342024 Guidance UpdateRaising the mid-point of guidance for full-year 2024 Adjusted EBITDA attributable to PAA by $75 million to a new range of $2.725 – $2.775 billionReiterating...

Continue reading

IES Holdings Reports Fiscal 2024 Third Quarter Results; Board Authorizes New $200 Million Share Repurchase Program

HOUSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended June 30, 2024. Third Quarter 2024 Highlights and Recent DevelopmentsRevenue of $768 million for the third quarter of fiscal 2024, an increase of 31% compared with $584 million for the same quarter of fiscal 2023 Operating income of $90.2 million for the third quarter of fiscal 2024, an increase of 163% compared with $34.3 million for the same quarter of fiscal 2023 Net income attributable to IES of $62.1 million for the third quarter of fiscal 2024, an increase of 175% compared with $22.5 million for the same quarter of fiscal 2023, and diluted earnings per share attributable to common stockholders of $2.67 for the third quarter of fiscal 2024, compared with $0.81 for...

Continue reading

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI) Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its unique off-target effects that block toxin uptake into the kidney tissue Arch continues to perform a Phase II trial for LSALT peptide targeting cardiac surgery-associated-AKI Drug toxins and CS-AKI account for up to 50% of all AKI occurring in hospitals, for which there is no treatment availableTORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that cilastatin, the Company’s second drug candidate for preventing acute kidney injury (AKI), will participate in the upcoming investigator led trial entitled “Prevention Of NephroToxin Induced Acute...

Continue reading

Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

Record second quarter 2024 revenue of $6.6 million, representing growth of 32% compared to the second quarter of 2023 150th Growth Direct® system placed with an existing top 15 global pharma customer First Growth Direct Rapid Sterility system placed with an existing top 10 global pharma customer Gross margin improved by 35 percentage points compared to the second quarter of 2023, and by 24 percentage points compared to the first quarter of 2024 Announces operational efficiency program that is expected to enable the Company to achieve positive cash flow without additional financing Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to full year 2023LEXINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”),...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.